Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985088 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older
A Phase 2 study of Influenza, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,343
- Enrollment target
- 14
- Study locations
NCT00985088 is a Phase 2 study of Influenza that has completed, run by GlaxoSmithKline. The registered enrollment target is 1,343 participants, below the 36,795-participant average among 156 other Influenza trials with a reported enrollment target (96% lower). The trial reports 14 study locations across 13 states.
The verdict
NCT00985088, a Phase 2 study of Influenza, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,343 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to characterize the safety and immunogenicity of the H1N1 (swine) flu vaccines GSK2340273A and GSK2340274A in adults 18 years of age or older. This protocol posting has been updated for sections impacted by the Protocol amendment 1, Sept 2009.
Conditions Studied
Interventions
- BIOLOGICAL GSK2340274A
- BIOLOGICAL GSK2340273A
- BIOLOGICAL Saline placebo
Study Locations (14)
Florida
- GSK Investigational Site - Jacksonville
- GSK Investigational Site - Miami
Alabama
- GSK Investigational Site - Huntsville
Idaho
- GSK Investigational Site - Meridian
Kansas
- GSK Investigational Site - Lenexa
Montana
- GSK Investigational Site - Missoula
Nevada
- GSK Investigational Site - Las Vegas
New Jersey
- GSK Investigational Site - Edison
New York
- GSK Investigational Site - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,343 participants |
| Start Date | 2009-10-11 |
| Est. Completion | 2010-12-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00985088
The ClinicalTrials.gov registry entry for NCT00985088 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,343 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,795-participant average among 156 other Influenza trials with a reported enrollment target (96% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 3 interventions - of which GSK2340274A is the first listed.
NCT00985088 reports 14 study locations spanning 13 distinct geographic areas - top geographies include Florida, Alabama, Idaho.
Frequently Asked Questions
What is clinical trial NCT00985088 about?
NCT00985088 is a clinical study titled "Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older". The purpose of this study is to characterize the safety and immunogenicity of the H1N1 (swine) flu vaccines GSK2340273A and GSK2340274A in adults 18 years of age or older. This protocol posting has been updated for sections impacted by the Protocol amendment 1, Sept 2009.
What is the current status of trial NCT00985088?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,343 participants. The study started on 2009-10-11. Estimated completion is 2010-12-16.
What conditions does trial NCT00985088 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT00985088?
The interventions under investigation include: GSK2340274A (BIOLOGICAL), GSK2340273A (BIOLOGICAL), Saline placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT00985088?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00985088 being conducted?
This trial has 14 study locations across Alabama, Florida, Idaho, Kansas, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
RECRUITING · Phase 2
-
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
RECRUITING · Phase 2
-
Systems Investigation of Vaccine Responses in Aging and Frailty
RECRUITING · Phase 2
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
RECRUITING · Phase 2
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.